BioCryst Pharmaceuticals Announces Focused Corporate Strategy and Restructuring

BioCryst Pharmaceuticals Announces Focused Corporate Strategy and Restructuring

By: 1888PressRelease - Full Feed

Posted on December 07, 2012 at 07:25 AM EST

BioCryst Pharmaceuticals, Inc. announced today that in response to recent events and an assessment of its assets, the Company is restructuring and implementing a focused strategy to advance its hereditary angioedema (HAE) and antiviral programs.

Related Stocks:

BioCryst Pharmaceuticals, Inc.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates